APA (7th ed.) Citation

Lu, H., Zhou, F., Rui, C., You, H., Zhang, W., Zhang, Y., . . . Wu, Q. (2024). Pharmacokinetic, bioequivalence, and safety assessments of two brands of 30-mg nifedipine controlled-release formulations in Chinese healthy subjects. International journal of clinical pharmacology and therapeutics, 62(10), 486-496. https://doi.org/10.5414/CP204605

Chicago Style (17th ed.) Citation

Lu, Huan, Fei Zhou, Cuijie Rui, Hen You, Wenhao Zhang, Yaxin Zhang, Juefang Ding, Shunbo Zhao, and Qiang Wu. "Pharmacokinetic, Bioequivalence, and Safety Assessments of Two Brands of 30-mg Nifedipine Controlled-release Formulations in Chinese Healthy Subjects." International Journal of Clinical Pharmacology and Therapeutics 62, no. 10 (2024): 486-496. https://doi.org/10.5414/CP204605.

MLA (9th ed.) Citation

Lu, Huan, et al. "Pharmacokinetic, Bioequivalence, and Safety Assessments of Two Brands of 30-mg Nifedipine Controlled-release Formulations in Chinese Healthy Subjects." International Journal of Clinical Pharmacology and Therapeutics, vol. 62, no. 10, 2024, pp. 486-496, https://doi.org/10.5414/CP204605.